Blood-brain barrier breakdown in the aging human hippocampus.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuron

• Publication date

  2015-01-21

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuron.2014.12.032PMID 25611508PMCID PMC4350773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of cortical superficial siderosis in a memory clinic population

  2014cited by this paper
• Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice

  2014cited by this paper
• Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown.

  2013influential reference
• Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease

  2013influential reference
• Pericyte loss influences Alzheimer-like neurodegeneration in mice

  2013influential reference
• The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients

  2013influential reference
• Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer's Disease Detected in vivo with Magnetic Resonance Imaging

  2013cited by this paper
• Magnetic Resonance Imaging Profile of Blood–Brain Barrier Injury in Patients With Acute Intracerebral Hemorrhage

  2013cited by this paper
• Innate immunity receptor CD36 promotes cerebral amyloid angiopathy

  2013cited by this paper
• The pathobiology of vascular dementia.

  2013influential reference
• Quantification of blood-to-brain transfer rate in multiple sclerosis.

  2013cited by this paper
• Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging.

  2012cited by this paper
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012influential reference
• Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability

  2012influential reference
• Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease

  2012influential reference
• Preclinical success against Alzheimer's disease with an old drug.

  2012cited by this paper
• The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy.

  2012influential reference
• Central nervous system pericytes in health and disease

  2011cited by this paper
• Adult hippocampal neurogenesis and its role in Alzheimer's disease

  2011cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011influential reference
• Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment

  2011influential reference
• Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping

  2011influential reference
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

  2011cited by this paper
• 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

  2010cited by this paper
• Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

  2010cited by this paper
• Pericytes are required for blood–brain barrier integrity during embryogenesis

  2010influential reference
• Pericytes regulate the blood–brain barrier

  2010influential reference
• Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

  2010cited by this paper
• Measurement of brain perfusion, blood volume, and blood‐brain barrier permeability, using dynamic contrast‐enhanced T1‐weighted MRI at 3 tesla

  2009cited by this paper
• SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells

  2009cited by this paper
• Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition

  2009cited by this paper
• The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery

  2009cited by this paper
• Alzheimer's Disease Neuroimaging Initiative

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008influential reference
• A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain

  2008cited by this paper
• Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.

  2007influential reference
• Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD

  2006cited by this paper
• The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers

  2006cited by this paper
• Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex

  2005cited by this paper
• Neurovascular regulation in the normal brain and in Alzheimer's disease

  2004influential reference
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier

  2002influential reference
• Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease.

  2002cited by this paper
• Cerebral microvascular pathology in aging and Alzheimer's disease.

  2001influential reference
• Staging of Alzheimer-related cortical destruction.

  1997cited by this paper
• Staging of Alzheimer-Related Cortical Destruction

  1997cited by this paper
• Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans.

  1992cited by this paper
• Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

  1990influential reference
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations

  1985cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper

• Cerebral haemodynamics and white matter hyperintensities: findings using non-invasive brain imaging

  2026cites this paper
• A multi-target therapeutic framework for Alzheimer's disease: an integrative mechanistic review.

  2026cites this paper
• The protective role of companion animal ownership in cognitive aging: current status of the literature.

  2026cites this paper
• Bridging White Matter Hyperintensities and Cognitive Dysfunction: The Status and Prospect of Radiomics in Cerebral Small Vessel Disease

  2026cites this paper
• Obesity as a catalyst for neurodegeneration.

  2026cites this paper
• Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment.

  2026cites this paper
• DRD2 Deficiency Underlies Pituitary Adenoma Dependent on Escherichia coli Translocation from the Gut.

  2026cites this paper
• Plasma p-Tau217 and amyloid-β oligomers as complementary biomarkers for differential diagnosis, comorbidity detection and disease monitoring in idiopathic normal pressure hydrocephalus.

  2026cites this paper
• Endothelial TRIM47 regulates blood-brain barrier integrity and cognition via the KEAP1/NRF2 signalling pathway in mice.

  2026cites this paper
• Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice

  2026cites this paper
• The C3–C3aR axis drives rotenone-induced cognitive damage via synaptic engulfment, dark microglia and PANoptosis

  2026cites this paper
• Bloodstream infections and Blood-Brain barrier Permeability: An observational cohort study.

  2026cites this paper
• Multidimensional integrative analysis unveils genetic architecture, risk factors, and health consequences of brain aging.

  2026cites this paper
• Spatial and spectral mapping of traffic-related nanoparticles in hippocampal subregions of an Alzheimer disease model.

  2026cites this paper
• Induction of neurodegeneration in the hippocampus of senescence-accelerated mouse-prone 8 (SAMP8) mice by blood-brain barrier-crossing serum amyloid P component

  2026cites this paper
• Cholesterol Lowering Alone Fails to Reverse Atherosclerotic Plaque Necrosis, Granulopoiesis, and Neurovascular Neutrophils in Middle‐Aged Mice

  2026cites this paper
• Subtle blood-brain barrier leakage quantification using DCE-MRI in subjective and mild cognitive impairment: A pilot sub-study of the Cognitive Ageing, Nutrition & Neurogenesis (CANN) trial

  2026cites this paper
• Traumatic Brain Injury Induces Senescence in Brain Microvasculature

  2026cites this paper
• Glioinflammation: disease-associated microglia and astrocytes in psychiatric disorders, neurodegeneration, and senescence.

  2026cites this paper
• Pharmaceutical Strategies for West Nile Virus in Europe, an Underrecognized Cause of Severe Disease and Mortality in Older Adults: From Supportive Care to Antiviral Development.

  2026cites this paper
• Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration

  2026cites this paper
• From Cerebrovascular Injury to Vascular Cognitive Impairment and Dementia: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles

  2026cites this paper
• Preoperative Anxiety and Postoperative Delirium: A Mini Review of the Association, Mechanisms, and Preventive Strategies

  2026cites this paper
• Strategies for blood-brain barrier rejuvenation and repair.

  2026cites this paper
• Mutations associated with Alzheimer's disease and aged serum synergistically elicit blood-brain barrier dysfunction in a tissue-engineered model.

  2026cites this paper
• Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration.

  2026cites this paper
• APOE4 Genotype is Associated with Reduced Cortical VEGFR2 (KDR) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study

  2026cites this paper
• Inflammation-Associated Mechanisms of Blood–Brain Barrier Disruption and Depression Pathogenesis in People with and Without HIV

  2026cites this paper
• Therapeutic targeting of neuroimmune mechanisms in neurodegeneration.

  2026cites this paper
• Off-Target Effects of Mirabegron on Muscarinic Receptors

  2026cites this paper
• Influence of feelings on the blood-brain barrier (BBB) and drug delivery.

  2025cites this paper
• Seizure frequency, APOE ε4, and cognitive function in older people with epilepsy

  2025cites this paper
• Understanding the Blood-Brain Barrier: From Physiology to Pathology.

  2025cites this paper
• Hypercholesterolemia, oxidative stress, and low-grade inflammation: a potentially dangerous scenario to blood–brain barrier

  2025cites this paper
• Cerebral hemodynamics evaluation of FLAIR vascular hyperintensity in TIA patients with large artery severe stenosis or occlusion

  2025cites this paper
• Inhibiting 15-PGDH blocks blood–brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury

  2025cites this paper
• Haemochromatosis Genotypes and Incident Dementia in a Prospective Study of Older Adults

  2025cites this paper
• RRAECL: A Riemannian manifold graph representation and enhanced contrastive learning framework for label-efficient Alzheimer's disease diagnosis

  2025cites this paper
• Decoding Alzheimer’s Disease: Single-Cell Sequencing Uncovers Brain Cell Heterogeneity and Pathogenesis

  2025cites this paper
• The Soluble Platelet‐Derived Growth Factor β Receptor Induces Postoperative Delirium by Downregulating the Clearance of β‐Amyloid in the Brain

  2025cites this paper
• Blood biomarkers of vascular dysfunction in small vessel disease progression: Insights from a longitudinal neuroimaging study

  2025cites this paper
• Amyotrophic lateral sclerosis and frontotemporal dementia mutation reduces endothelial TDP-43 and causes blood-brain barrier defects

  2025cites this paper
• Aging‐Induced Episodic‐Like Memory Impairment Could be Alleviated by Melatonin Treatment via Preserving Blood–Brain Barrier Integrity and Upregulating CRTC1

  2025cites this paper
• Hippocampal-subfield macro- and microstructural changes in cerebral small vessel disease with mild cognitive impairment.

  2025cites this paper
• Red Blood Cell-Derived Exosomes as Mediators of Age-Related Neurodegeneration

  2025cites this paper
• Exercise Delays Brain Ageing Through Muscle‐Brain Crosstalk

  2025cites this paper
• Senescent Endothelial Cells in Cerebral Microcirculation Are Key Drivers of Age‐Related Blood–Brain Barrier Disruption, Microvascular Rarefaction, and Neurovascular Coupling Impairment in Mice

  2025cites this paper
• Understanding Cognitive Decline in Aging: Mechanisms and Mitigation Strategies – A Narrative Review

  2025cites this paper
• Restoration of blood brain barrier integrity post neurosurgical resection in drug resistant epilepsy.

  2025cites this paper
• The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia

  2025cites this paper
• Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery

  2025cites this paper
• Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD mice

  2025cites this paper
• Characterization of the glymphatic system and early-phase β-amyloid imaging in Alzheimer's disease: a simultaneous PET/MR study.

  2025cites this paper
• Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications

  2025cites this paper
• Vascular depression: A comprehensive exploration of the definition, mechanisms, and clinical challenges.

  2025cites this paper
• Blood–Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes

  2025cites this paper
• p16-expressing microglia and endothelial cells promote tauopathy and neurovascular abnormalities in PS19 mice.

  2025cites this paper
• Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups

  2025cites this paper
• Exploring the anti-Alzheimer's disease mechanisms of edible medicinal plant Polygonum cuspidatum by integrating network pharmacology and molecular docking

  2025cites this paper
• Neurovascular coupling dysfunction in encephalopathy: pathophysiological advances and clinical implications

  2025cites this paper
• Impacts of systemic milieu on cerebrovascular and brain aging: insights from heterochronic parabiosis, blood exchange, and plasma transfer experiments

  2025cites this paper
• A Narrative Review Evaluating Diet and Exercise as Complementary Medicine for the Management of Alzheimer’s Disease

  2025cites this paper
• Cd248a regulates pericyte development and viability in zebrafish

  2025cites this paper
• Neuroglia in aging.

  2025cites this paper
• Sleep links hippocampal propensity for epileptiform activity to its viscerosensory inputs

  2025cites this paper
• Longitudinal Investigation of Brain and Spinal Cord Pericytes After Inducible PDGFRβ + Cell Ablation in Adult Mice

  2025cites this paper
• The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

  2025cites this paper
• The role of VEGF in vascular dementia: impact of aging and cellular senescence

  2025cites this paper
• Probiotics as a possible novel therapeutic option to mitigate perioperative neurocognitive disorders: A review exploring the latest research findings.

  2025cites this paper
• Glycocalyx dysregulation impairs blood–brain barrier in ageing and disease

  2025cites this paper
• MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection

  2025cites this paper
• The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease

  2025cites this paper
• Plasma exosomal miRNA expression and gut microbiota dysbiosis are associated with cognitive impairment in Alzheimer’s disease

  2025cites this paper
• Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.

  2025cites this paper
• Age- and ApoE Genotype-Dependent Transcriptomic Responses to O3 in the Hippocampus of Mice

  2025cites this paper
• Decreased water exchange rate across the blood–brain barrier throughout the Alzheimer's disease continuum: Evidence from Chinese data

  2025cites this paper
• Exploring the microbiota-gut-brain axis: impact on brain structure and function

  2025cites this paper
• Tracer kinetic model detecting heterogeneous blood–brain barrier permeability to water and contrast agent in Alzheimer's disease and dementia with Lewy bodies

  2025cites this paper
• An Update on Neuroaging on Earth and in Spaceflight

  2025cites this paper
• Altered Clearance in Alzheimer's Disease and Cerebral Amyloid Angiopathy.

  2025cites this paper
• Spatiotemporal analysis of gene expression in the human dentate gyrus reveals age-associated changes in cellular maturation and neuroinflammation.

  2025cites this paper
• Visual analysis of emerging topics and trends in contrast agent extravasation research in medical imaging: a bibliometric study using CiteSpace and VOSviewer

  2025cites this paper
• The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias

  2025influential citation
• ‘Slime’ keeps the brain safe ― and could guard against ageing

  2025cites this paper
• Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies

  2025cites this paper
• Aging and ischemic stroke: mechanisms, trends, and strategies for improved outcomes

  2025cites this paper
• Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

  2025cites this paper
• Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.

  2025cites this paper
• Genetically supported targets and drug repurposing for brain aging: A systematic study in the UK Biobank

  2025cites this paper
• Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies

  2025cites this paper
• Endothelial TDP-43 depletion disrupts core blood–brain barrier pathways in neurodegeneration

  2025cites this paper
• The blood–brain barrier as a treatment target for neurodegenerative disorders

  2025cites this paper
• Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrier

  2025cites this paper
• Traumatic Brain Injury and Alzheimer’s Disease: A Shared Neurovascular Hypothesis

  2025cites this paper
• The relationship between Alzheimer's disease and intracerebral hemorrhage based on Mendelian randomization

  2025cites this paper
• Quantitative PET imaging and modeling of molecular blood-brain barrier permeability

  2025cites this paper
• Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review

  2025influential citation
• Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls.

  2025influential citation
• Shared Mechanisms of Blood-Brain Barrier Dysfunction and Neuroinflammation in Coronavirus Disease 2019 and Alzheimer Disease

  2025cites this paper
• Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation

  2025cites this paper